A DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL PHARMACOLOGICAL STUDY OF TAS-303 IN FEMALE PATIENTS WITH STRESS URINARY INCONTINENCE

Mapping Intimacies ◽

10.26226/morressier.59b63e41d462b80292389510 ◽

2017 ◽

Author(s):

Makoto Yono

Keyword(s):

Urinary Incontinence ◽

Stress Urinary Incontinence ◽

Pharmacological Study ◽

Double Blind ◽

Double Blind Placebo ◽

Female Patients

Download Full-text

Stress urinary incontinence in postmenopausal women treated with oral estrogen (estriol) and an alpha-adrenoceptor-stimulating agent (phenylpropanolamine): A randomized double-blind placebo-controlled study

International Urogynecology Journal ◽

10.1007/bf00600025 ◽

1990 ◽

Vol 1 (2) ◽

pp. 74-79 ◽

Author(s):

S. Walter ◽

B. Kj�rgaard ◽

G. Lose ◽

J. T. Andersen ◽

L. Heisterberg ◽

...

Keyword(s):

Urinary Incontinence ◽

Stress Urinary Incontinence ◽

Postmenopausal Women ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Alpha Adrenoceptor ◽

Download Full-text

Re: The Efficacy and Safety of PSD503 (Phenylephrine 20%, w/w) for Topical Application in Women with Stress Urinary Incontinence. A Phase II, Multicentre, Double-Blind, Placebo Controlled, 2-Way Cross Over Study

The Journal of Urology ◽

10.1016/j.juro.2012.08.157 ◽

2012 ◽

Vol 188 (6) ◽

pp. 2301-2302

Author(s):

Alan J. Wein

Keyword(s):

Urinary Incontinence ◽

Stress Urinary Incontinence ◽

Phase Ii ◽

Topical Application ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

A phase II, multi-centre, double-blind, placebo-controlled, 2-way cross-over study to evaluate efficacy, plasma concentrations and safety of 0.25 mL of 20 % w/w PSD503 for topical application in female volunteer patients with stress urinary incontinence

http://isrctn.org/> ◽

10.1186/isrctn39853232 ◽

2012 ◽

Author(s):

Sheryl Caswell

Keyword(s):

Urinary Incontinence ◽

Stress Urinary Incontinence ◽

Phase Ii ◽

Topical Application ◽

Plasma Concentrations ◽

Female Volunteer ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Transvaginal electrical stimulation with surface-EMG biofeedback in managing stress urinary incontinence in women of premenopausal age: a double-blind, placebo-controlled, randomized clinical trial

International Urogynecology Journal ◽

10.1007/s00192-013-2071-5 ◽

2013 ◽

Vol 24 (10) ◽

pp. 1631-1638 ◽

Author(s):

Robert Terlikowski ◽

Bozena Dobrzycka ◽

Maciej Kinalski ◽

Anna Kuryliszyn-Moskal ◽

Slawomir J. Terlikowski

Keyword(s):

Clinical Trial ◽

Urinary Incontinence ◽

Electrical Stimulation ◽

Stress Urinary Incontinence ◽

Randomized Clinical Trial ◽

Surface Emg ◽

Emg Biofeedback ◽

Double Blind ◽

Double Blind Placebo ◽

Managing Stress

Download Full-text

A randomized, double-blind, placebo-controlled comparison of the effect of nitrofurantoin monohydrate macrocrystals on the development of urinary tract infections after surgery for pelvic organ prolapse and/or stress urinary incontinence with suprapubic catheterization

American Journal of Obstetrics and Gynecology ◽

10.1016/j.ajog.2004.03.088 ◽

2004 ◽

Vol 191 (1) ◽

pp. 182-187 ◽

Author(s):

Rebecca G Rogers ◽

Dorothy Kammerer-Doak ◽

Ambre Olsen ◽

Peter K Thompson ◽

Mark D Walters ◽

...

Keyword(s):

Urinary Incontinence ◽

Urinary Tract ◽

Pelvic Organ Prolapse ◽

Stress Urinary Incontinence ◽

Urinary Tract Infections ◽

Pelvic Organ ◽

Double Blind ◽

Double Blind Placebo ◽

Suprapubic Catheterization ◽

Tract Infections

Download Full-text

A randomized, double-blind, placebo-controlled clinical trial: evaluating safety and efficacy of a composition of purified and specific cytoplasm extracts of pollen (PSCEP), pumpkin seed extract and vitamin E (Femaxeen®) in women with stress urinary incontinence

Maturitas ◽

10.1016/j.maturitas.2019.04.154 ◽

2019 ◽

Vol 124 ◽

pp. 167

Author(s):

Santiago Palacios ◽

Marieta Ramirez ◽

Mariella Lilue

Keyword(s):

Clinical Trial ◽

Urinary Incontinence ◽

Vitamin E ◽

Stress Urinary Incontinence ◽

Seed Extract ◽

Controlled Clinical Trial ◽

Double Blind ◽

Pumpkin Seed ◽

Safety And Efficacy ◽

Double Blind Placebo

Download Full-text

The efficacy and safety of PSD503 (phenylephrine 20%, w/w) for topical application in women with stress urinary incontinence. A phase II, multicentre, double-blind, placebo controlled, 2-way cross over study

European Journal of Obstetrics & Gynecology and Reproductive Biology ◽

10.1016/j.ejogrb.2011.07.030 ◽

2011 ◽

Vol 159 (2) ◽

pp. 457-460 ◽

Author(s):

Dudley Robinson ◽

Paul Abrams ◽

Linda Cardozo ◽

Julie Ellis-Jones ◽

Pat Heath ◽

...

Keyword(s):

Urinary Incontinence ◽

Stress Urinary Incontinence ◽

Phase Ii ◽

Topical Application ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Phenylpropanolamine in treatment of female stress urinary incontinence Double-blind placebo controlled study in 24 patients

Urology ◽

10.1016/0090-4295(87)90314-1 ◽

1987 ◽

Vol 30 (4) ◽

pp. 398-403 ◽

Author(s):

Lars Collste ◽

Marianne Lindskog

Keyword(s):

Urinary Incontinence ◽

Stress Urinary Incontinence ◽

Female Stress Urinary Incontinence ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

A PHASE 2, 8-WEEK, MULTI-CENTER, RANDOMIZED DOUBLE- BLIND, PLACEBO CONTROLLED, PARALLEL GROUP STUDY EVALUATING THE EFFICACY, TOLERABILITY AND SAFETY OF [S,S] - REBOXETINE (PNU-165442G) FOR STRESS URINARY INCONTINENCE IN WOMEN

The Journal of Urology ◽

10.1016/s0022-5347(08)61675-4 ◽

2008 ◽

Vol 179 (4S) ◽

pp. 569-570 ◽

Author(s):

Norman Zinner ◽

David Scholfield ◽

Koshika Soma ◽

Amanda Darekar ◽

Lee Grant ◽

...

Keyword(s):

Urinary Incontinence ◽

Stress Urinary Incontinence ◽

Phase 2 ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group Study ◽

Download Full-text

The Efficacy and Safety of PSD503 (phenylephrine 20% w/w) for Topical Application in Women with Stress Urinary Incontinence. A Phase II, Multi-Centre, Double-Blind, Placebo-Controlled, Cross-Over Study

UroToday International Journal ◽

10.3834/uij.1939-4810.2008.06.39 ◽

2008 ◽

Author(s):

Linda Cardozo

Keyword(s):

Urinary Incontinence ◽

Stress Urinary Incontinence ◽

Phase Ii ◽

Topical Application ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text